Medpace Holdings (MEDP) Price to Earnings (2016 - 2026)

Medpace Holdings (MEDP) has reported Price to Earnings for 11 consecutive years, with 121.79 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings rose 24.7% year-over-year to 121.79; the trailing twelve-month figure through Jun 2026 stood at 30.07 (up 42.69% YoY), and the FY2025 full-year result was 35.32, up 40.36% from the prior year.
• Price to Earnings rose to 121.79 in Q2 2026 per MEDP's latest filing, from 110.71 in the prior quarter.
• Across five years, Price to Earnings topped out at 144.51 in Q2 2024 and bottomed at 74.03 in Q3 2022.
• Historically, Price to Earnings has averaged 105.43 across 5 years, with a median of 106.45 in 2023.
• The sharpest annual moves came in 2022 and 2024: Price to Earnings plunged 47.14% in 2022, then soared 54.5% in 2024.
• Over 5 years, Price to Earnings stood at 96.17 in 2022, then climbed by 25.18% to 120.39 in 2023, then decreased by 27.77% to 86.97 in 2024, then jumped by 35.59% to 117.92 in 2025, then advanced by 3.29% to 121.79 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 121.79, 110.71, and 117.92 for Q2 2026, Q1 2026, and Q4 2025 respectively.